UNC Lineberger was well represented at the Society of Gynecologic Oncology 2023 Annual Meeting on Women’s Cancer in Tampa, Florida, with faculty and trainees presenting research findings, receiving honors and being elected to leadership roles.
Victoria Bae-Jump, MD, PhD, professor of gynecologic oncology, was presented with an Innovation Award, an honor that recognizes her for significantly impacting the understanding of and/or approaches to the prevention, diagnosis or treatment of gynecologic cancers.
John Soper, MD, professor of gynecologic oncology, received the Surgical Mentor Award for his commitment to mentoring surgical fellows.
Bae-Jump was elected to the SGO board of directors.
Wendy Brewster, MD, PhD, professor of gynecologic oncology, is president-elect of SGO and will serve her term in 2024-25.
Intermittent fasting alone or in combination with paclitaxel is a highly effective treatment strategy in a pre-clinical model of obesity-driven endometrial cancer, Meredith Newton, MD, presenting for Wesley Burkett, MD, both are third year gynecologic oncology fellows. (Mentor Bae-Jump lab)
Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer, Catherine John, MD, second year gynecologic oncology fellow. (Mentor Bae-Jump lab)
Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer, Catherine John, MD. (Mentor Bae-Jump lab)
Clinical Calculator to Predict Loss of Independence after Surgery for Endometrial cancer, Miller Singleton, MD, third year OB/GYN resident. (Mentor Leslie Clark, MD)
Racial differences along the timeline of care among women with gynecologic malignancies treated at a tertiary care center, Miller Singleton, MD. (Mentor Leslie Clark, MD)
A Patient-Reported Outcomes Measure Derived from the Cancer-Specific Geriatric Assessment Predicts Frailty in Women with Ovarian Cancer, Lindsey Buckingham, MD, adjuvant professor UNC OB/GYN and Novant Health Cancer Institute/New Hanover.
Differences in Palliative Care Referral Rates by Gynecologic Malignancy, Ana Kouri, MD, third year OB/GYN resident. (Mentor Leslie Clark, MD)
Sulindac, a COX1/COX2 Inhibitor, Exhibits Anti-tumorigenic Effects in Obesity-driven Models of Endometrioid Endometrial Cancer, Catherine John, MD. (Mentor Bae-Jump lab)